Peer-reviewed journal articles (257)
  1. 71. Remmelink, M., de Leval, L., Decaestecker, C., Duray, A., Crompot, E., Sirtaine, N., André, S., Kaltner, H., Leroy, X., Gabius, H.-J., & Saussez, S. (2011). Quantitative immunohistochemical fingerprinting of adhesion/growth-regulatory galectins in salivary gland tumours: divergent profiles with diagnostic potential. Histopathology, 58(4), 543-556. doi:10.1111/j.1365-2559.2011.03776.x
  2. 72. Ernoux-Neufcoeur, P., Arafa, M., Decaestecker, C., Duray, A., Remmelink, M., Leroy, X., Herfs, M., Somja, J., Depuydt, C. E., Delvenne, P. O., & Saussez, S. (2011). Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma. Journal of cancer research and clinical oncology, 137(1), 173-181. doi:10.1007/s00432-010-0871-2
  3. 73. Rorive, S., Moles Lopez, X., Maris, C., Trepant, A.-L., Sauvage, S., Sadeghi-Meibodi, N., Roland, I., Decaestecker, C., & Salmon, I. (2010). TIMP-4 and CD63: new prognostic biomarkers in human astrocytomas. Modern pathology, 23(10), 1418-1428. doi:10.1038/modpathol.2010.136
  4. 74. Cludts, S., Decaestecker, C., Johnson, B., Lechien, J., Leroy, X., Kindt, N., Kaltner, H., André, S., Gabius, H.-J., & Saussez, S. (2010). Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinoma. Anticancer research, 30(9), 3313-3319.
  5. 75. Le Calve, B., Rynkowski, M., Le Mercier, M., Bruyère, C., Lonez, C., Gras, T., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Ruysschaert, J. M., Kiss, R., & Lefranc, F. (2010). Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression. Neoplasia (New York, N.Y.), 12(9), 727-739. doi:10.1593/neo.10526
  6. 76. Balde, E. S., Megalizzi, V., Traoré, M. S., Cos, P., Maes, L., Decaestecker, C., Pieters, L., & Balde, A. (2010). In vitro antiprotozoal, antimicrobial and antitumor activity of Pavetta crassipes K. Schum leaf extracts. Journal of ethnopharmacology, 130(3), 529-535. doi:10.1016/j.jep.2010.05.042
  7. 77. Rorive, S., D'Haene, N., Fossion, C., Delpierre, I., Abarguia, N., Avni, E., Decaestecker, C., & Salmon, I. (2010). Ultrasound-guided fine-needle aspiration of thyroid nodules: stratification of malignancy risk using follicular proliferation grading, clinical and ultrasonographic features. European journal of endocrinology, 162(6), 1107-1115. doi:10.1530/EJE-09-1103
  8. 78. Saussez, S., de Leval, L., Decaestecker, C., Sirtaine, N., Cludts, S., Duray, A., Chevalier, D., André, S., Gabius, H.-J., Remmelink, M., & Leroy, X. (2010). Galectin fingerprinting in Warthin's tumors: lectin-based approach to trace its origin? Histology and histopathology, 25(5), 541-550.
  9. 79. Mancilla, V., Decaestecker, C., Ligny, C., Matagne, L., Simon, P., & Courtmans, I. (2010). La surdité moyenne: Étiologie, évaluation linguistique et scolaire. Cahiers de l'audition, 23(3), 5-9.
  10. 80. Pozdzik, A., Berton, A., Schmeiser, H. H., Missoum, W., Decaestecker, C., Salmon, I., Vanherweghem, J.-L., & Nortier, J. (2010). Aristolochic acid nephropathy revisited: a place for innate and adaptive immunity? Histopathology, 56(4), 449-463. doi:10.1111/j.1365-2559.2010.03509.x
  11. 81. Pozdzik, A., Berton, A., Schmeiser, H. H., Missoum, W., Decaestecker, C., Salmon, I., Vanherweghem, J.-L., & Nortier, J. (2010). Aristolochic acid nephropathy revisited: a place for innate and adaptive immunity? Histopathology, 56(4), 449-463. doi:10.1111/j.1365-2559.2010.03509.x
  12. 82. Lamoral-Theys, D., Decaestecker, C., Mathieu, V., Dubois, J., Kornienko, A., Kiss, R., Evidente, A., & Pottier, L. (2010). Lycorine and its derivatives for anticancer drug design. Mini-reviews in medical chemistry, 10(1), 41-50. doi:10.2174/138955710791112604
    13. << Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Next >>